Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.88, $0.26 better than the analyst estimate of $1.62. Revenue for the quarter came in at $52.3 billion versus the consensus estimate of $50.9 billion.

GUIDANCE:

Cardinal Health sees FY2025 EPS of $7.75-$7.90, versus the consensus of $7.63.

This guidance includes an update to the company\'s Pharmaceutical and Specialty Solutions segment profit outlook to 4% to 6% growth, from 1% to 3% growth. The company also updated its Global Medical Products and Distribution segment profit outlook to $140 million to $175 million, from approximately $175 million, primarily due to the impact of higher health and welfare costs. Additionally, the company updated expectations for its adjusted free cash flow to $1.0 billion to $1.5 billion, from approximately $1.0 billion.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.